CALBIO2012 is your gateway to California’s life science community. We’ll work with you to improve your visibility with the world’s leading companies. Reach potential clients, investors and partners with several customized packages to meet your marketing needs.
| Sponsor/Exhibit Opportunities | Download Sponsorship Prospectus |
 |
Almac is a financially stable, privately owned organisation with over 3,300 employees located within the US and UK. Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 40+ years.Almac provides a seamless, fast and efficient route from drug discovery through to market. Our integrated range of services include:
Research: Focused on the delivery of biomarker solutions and supporting biomarker strategy for drug development, which underpins the delivery of personalised medicine. Chemical & Pharmaceutical Development: Accelerating the development of customers’ drug candidates through the effective integration of science and manufacturing to provide drug substance & product. Clinical Development: Fully integrated world class clinical trial supplies & IVR/IWR technology. Commercial: Solid dosage form commercial manufacture and packaging for EU & US markets. Product launch & distribution services to facilitate EU market access for non-EU product. |
 |
Arnold & Porter LLP, an 800 lawyer firm with offices in the US and Europe, is ideally positioned to serve the needs of the Life Sciences sector. For over six decades, our team of more than 75 Life Sciences attorneys — including lawyers based in San Francisco, Palo Alto and Los Angeles — has advised companies large and small throughout every stage of the product life cycle. Our service offerings include corporate transactions (including strategic alliances, licensing and co-development agreements, as well as venture capital and early stage financing); regulatory counseling and compliance, IP, and litigation. |
 |
BioCentury publishes BioCentury: The Bernstein Report on BioBusiness, a weekly business journal that provides independent coverage and analysis of biopharma industry developments. In addition, BioCentury publishes the BioCentury Extra, a daily recap of breaking industry events monitored throughout the day. The company also markets BCIQ: BioCentury Online Intelligence its biopharma-dedicated data solutions resource comprised of company profiles, financings and pipeline analysis. SciBX: Science-Business eXchange is a weekly journal published in collaboration with Nature Publishing Group that examines commercially promising translational science selected each week from research journals around the globe. For more information, visit www.biocentury.com and www.scibx.com. |
 |
BioSurplus is a leading provider of pre-owned scientific instruments, equipment management solutions and lab equipment auctions to the life sciences industry. Founded in 2002, the company offers solutions for every stage of the laboratory equipment life cycle — from buying to selling — and managing every process in between.Whether you need to buy equipment, sell surplus assets, manage your equipment inventory, or make repairs to existing assets, BioSurplus provides optimal solutions to meet your requirements.
BioSurplus is headquartered in San Diego, CA, with showrooms in San Diego and the San Francisco Bay Area. The company also has offices in Boston, Massachussetts, and Incheon, South Korea. BioSurplus offers services regionally and sells equipment worldwide. To view inventory for direct purchase on the BioSurplus website, please visit www.biosurplus.com. The company also auctions surplus lab equipment on its secure online platform at auctions.biosurplus.com. For more information please send an email to info@biosurplus.com or call +1 (858) 550-0800 x201. |
 |
BioWorld® Today, the news source of record for the biopharmaceutical industry, is read by biotechnology professionals worldwide for its hard-hitting, objective news reporting. BioWorld publishes information that is researched and written by the top business and science reporters in the industry. With nearly 20 writers spread throughout eight countries, BioWorld covers news on public companies and hard-to-find information on private companies. This news coverage of the biotechnology industry is 100 percent original and available only at BioWorld.
Feel free to contact a customer service at (800) 688-2421 or e-mail us at customerservice@bioworld.com for a 30-day Risk FREE trial. |
 |
Bloomberg Government is the single source for professionals who need to understand the business impacts of government actions so they can work quickly, decisively and effectively. This comprehensive, subscription-based, online tool collects best-in-class data, provides high-end analysis and analytic tools, and delivers deep, reliable, timely and unbiased reporting from a team of more than 2,300 journalists and multimedia specialists worldwide. Our dedicated editorial teams include award-winning editors and reporters along with former congressional staffers, regulatory officials, industry veterans, economists, and financial analysts, working to cover key industry sectors (including health care, energy, defense, finance, transportation, and tech/telecom) and cross-cutting areas such as trade, taxation, and labor. By linking the reporting and analysis of our teams to a fully customizable console of tools and resources, Bloomberg Government helps everyone from Congressional staffers and C-Suite executives, to government affairs professionals and sales executives do their jobs better. |
 |
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. The family-owned company has been committed for more than 125 years to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. With its global development and manufacturing facilities in Fremont (US), Biberach (Germany), and Vienna (Austria) Boehringer Ingelheim is one of the leaders in contract manufacturing of biopharmaceuticals born from 35 years of experience – and 19 commercial products. All types of services from mammalian or microbial cell line development to final drug production regardless of project stage or scale can be provided. Based on its expertise and manufacturing excellence Boehringer Ingelheim delivers multiple molecule classes such as monoclonal antibodies, recombinant proteins, interferons, enzymes, fusion molecules and plasmid DNA to its customers. |
 |
Canale Communications is a public and investor relations agency laser focused on building reputation equity for our life science clients. Reputation equity is the stuff that gives you the credibility to raise capital, the authority to launch a product, the power to influence perception, and the ability to navigate the volatile life sciences marketplace. Whether you’re a start-up that needs to get on the radar with venture capitalists or a diagnostic firm preparing for a product launch – we’ll help you build the value of your brand in a way that leads to enhanced, sustained business performance. The CanaleComm team functions as part of your internal team: we take a seat at the table, we care about your products as if they were our own, and we learn your story well enough to know what you need without being told… now that’s Statistically Significant. |
 |
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin’s lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies. |
 |
Compliance Implementation Services (CIS) is a life sciences consulting firm specializing in compliance strategies for pharmaceutical, biotech, and medical device companies, from global clinical research and development, through manufacturing, commercial compliance, and government programs. CIS provides its clients with a deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions to establish a “Culture of Compliance” that is both meaningful and sustainable. |
 |
Comerica Bank‘s Technology and Life Sciences Division is one of the nation’s leading technology banking practices, offering a wide range of financial services tailored to corporate customers, entrepreneurs, venture capital firms and their portfolio companies. Experienced bankers provide credit and financial services and products to young, growing, venture-backed technology, life sciences and alternative energy/clean technology companies, as well as their more mature counterparts. The Technology and Life Sciences Division is headquartered in Palo Alto, Calif. and serves all major U.S. technology centers from offices coast-to-coast. Comerica Bank, founded more than 162 years ago, is a subsidiary of Comerica Inc. (NYSE: CMA), a Dallas-based company that is one of the nation’s oldest and most stable financial institutions. The financial services company, one of the 25 largest in the U.S., has been building and investing in communities since its forerunner institution was formed in Michigan in 1849. |
 |
As the world’s leading provider of science and health information, Elsevier serves more than 30 million scientists, students and health and information professionals worldwide. We help customers advance science and health by providing world-class information and innovative tools that help them make critical decisions, enhance productivity and improve outcomes. In short, Elsevier’s information solutions increase the value of content and empower you to accelerate scientific research. Stop by our booth, #300 for a personalized demo of our world class online information solutions! |
 |
Fleishman-Hillard Inc., one of the world’s leading strategic communications firms, has built its reputation on creating integrated solutions that deliver what its clients value most: meaningful, positive and measurable impact on the performance of their organizations. The firm is widely recognized for excellent client service and a strong company culture founded on teamwork, integrity and personal commitment. Based in St. Louis, the firm operates throughout North America, Europe, Asia Pacific, Middle East, Africa and Latin America through its 80 owned offices. For more information, visit the Fleishman-Hillard website at www.fleishmanhillard.com. |
 |
For more than 25 years, Foley’s Life Sciences Industry Team has provided comprehensive legal services for life sciences enterprises. The cornerstone of our success is our unique ability to blend technical and legal insights with an understanding of our clients’ real-world business needs. Our cross-disciplinary service team effectively melds legal service in the areas of business, IP, health care, and FDA regulatory law. With special focus in the areas of personalized medicine, pharmaceutical and biotech patenting, comprehensive service with FDA regulatory, compliance, and enforcement, and a collaborations and licensing practice all operating within a global scope, Foley & Lardner LLP offers clients a 360—degree approach to their life science technologies. |
 |
Hantel Technologies is a provider of fast and highly flexible contact services for the development, engineering, and manufacturing of innovative drug delivery and other complementary devices needed to support the biotechnology industry.
Hantel can assist you in developing a broad spectrum of medical devices and life sciences instrumentation. Our leading edge medical device product development team possesses strong mechanical, electrical, and system integration skills. We utilize our proven design-to-manufacturing process to design your device for clinical studies and commercialization. Hantel’s highly skilled manufacturing personnel are ready to support the assembly and packaging of your medical product. Hantel is widely recognized throughout the medical device industry for our focus and dedication to excellence and quick turnaround. Hantel has on site a CNC machining center and manual mills and lathes. Our personnel provide rapid prototypes and production units with high accuracy and precision. |
 |
With over 6.3 million square feet spanning the dynamic coast of California, HCP, Inc. is the largest owner of life science real estate on the West Coast with a portfolio that offers exceptional views and serene work environments ideal for inspiration and innovation. Situated in prime life science clusters, users are surrounded by cutting-edge technology, prestigious academics, and scientific leadership. Best practices for sustainable design guarantee quality life science facilities with the ability to accommodate a wide variety of complex users. HCP is fully committed to supporting California’s scientific discovery by way of newly constructed and superior research space. HCP is one of the largest publicly-traded (NYSE: HCP) real estate investment trusts focused on the healthcare industry and is a member of the S&P 500. Established in 1985, HCP runs over 1,000 properties in 46 states across various property types, including life sciences, office, medical office, senior housing, hospital & skilled nursing. |
 |
Founded in 1992, Health Advances is a leading healthcare strategy firm advising clients in the biopharma, diagnostic, device, and healthcare services sectors, as well as investors and non-profit organizations. Operating at the intersection of science, technology, and business strategy, Health Advances provides clients with innovative solutions based on deep industry insight, analytical rigor, and an objective perspective. Healthcare executives rely on our professionals to help them make confident decisions involving the greatest challenges in the commercialization of medical technologies and services throughout the world. |
 |
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas. The Company’s Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research offers full-service global drug development services from early stage strategic protocol development and commercial planning consulting through NDA submission. For more information, please visit www.incresearch.com. |
 |
As a global leader in healthcare, Novartis is dedicated to researching, developing, manufacturing and successfully marketing a range of innovative drugs, diagnostics, and vaccines designed to prevent and cure diseases to improve medical outcomes. Since the 1980s, Novartis has enjoyed a growing presence in California fueled by access to rich intellectual talent and collaborations with academic institutions and biotechnology companies.Today, Novartis Diagnostics, the Novartis Institutes for Biomedical Research (NIBR) and its Genomics Institute of the Novartis Research Foundation (GNF), Novartis Pharmaceuticals, and Genoptix, part of Novartis Molecular Diagnostics, have operations in California. Together these sites focus on drug discovery, diagnostic tests and lab services, blood screening, drug and device development, and pharmaceutical manufacturing, and employ more than 3,300 associates across the state. |
 |
OUM is one of the leading professional services firms in California. Our specialty is providing audit, assurance, tax, and advisory services to public and private companies in the life sciences industry. Our dedicated life sciences group serves public and private companies in the biotechnology, specialty pharma, medical device, and other sectors.Our firm has over seventy professionals, including partners, managers and staff formerly with Big 4 firms. We stress active and ongoing partner involvement, candid and timely communication, and continuity of experienced professional staff.We are an independent member of the BDO Seidman Alliance. BDO is the fifth largest accounting and consulting network in the world, with member firms in 110 countries. Our affiliation affords us technical expertise, quality assurance, resources in specialized areas, staff training and learning systems, national and international offices, and the latest technical and reporting developments. |
 |
Patient Recruiters International (PRI) combines new and exciting multimodal direct patient access recruitment strategies with traditional time-tested media to achieve patient recruitment objectives of research studies. As an innovative patient recruitment services organization, PRI offers targeted direct patient access, online patient communications, customized social media initiatives, and referral methods that have short start-up times. PRI’s direct patient access solutions include GoHealthPanel.com, a general population site designed to create a large community of ailment sufferers wanting to become involved in research studies. PRI’s method of using patient databases and online communities has been successfully proven over its 12-year history under BioTrak Research with 300 research studies involving patients, pharmacists, and healthcare professionals. PRI has a complete Good Clinical Practice (GCP) program aimed at industry best standards. This translates to quality, compliance, confidence, and the ability to go deeper in the patient prescreening process for research studies. |
 |
Sidley Austin LLP is one of the world’s largest law firms with approximately 1700 lawyers and a global footprint with offices in 18 cities. We have a truly global interdisciplinary Life Sciences practice top-ranked in the U.S., EU and China. Our services focus on complex matters involving the development, manufacturing and marketing of products regulated by national and international agencies. Our group is comprised of lawyers from many different practices. With the diverse skill sets and in-depth industry experience, we provide seamless and integrated quality legal services to meet the needs of clients throughout the entire product life cycle. We provide legal service to pharmaceutical, biotechnology, medical device, food, dietary supplement and cosmetics companies, as well as hospitals, healthcare providers, research institutions and industry associations. Our clients range from established multi-national drug and device companies with blockbuster products to smaller biotech start-ups with their first viable products. |
 |
Ron Leuty covers all facets of the biotech industry for the San Francisco Business Times including the companies, the leaders, and the issues. Ron focuses on the business side of biotech, while explaining the science in a way readers can understand. His coverage illuminates the human side with a focus on the scientists seeking to solve health problems and the executives working to bring new treatments to market, as well as the people for whom the drugs will mean better lives. |
 |
UPS is a global leader in logistics, offering a broad range of solutions including the transportation of packages and freight, the facilitation of international trade, and the deployment of advanced supply chain technology to more efficiently manage the world of business. UPS’s transportation and distribution capabilities and culture of precision and innovation makes us an excellent fit for the healthcare industry, where reliability and quality assurance are essential and logistics impacts lives around the world. We partner with many healthcare companies to choreograph logistics of all types, from factory floor to a patient’s front door, and we do it in the reliable, compliant way that has made us an industry leader. Our gold standard of compliance is built from our dedicated people, and our logistics and distribution facilities that together safeguard healthcare products against loss, damage and theft, enabling you to focus on your customers and your business while ensuring business continuity and speed to market. Our attitude toward healthcare is summed up by the philosophy: “It’s a patient, not a package”®. For more information on UPS’s healthcare services, visit ups.com/healthcare. |